How the Long-term Use of Aspirin Impacts Mortality, Renal Deterioration in Patients With Chronic Kidney Disease
Jun Ling Lu, MD, assistant professor, University of Tennessee Health Science Center, addresses the study findings regarding how the long-term use of aspirin impacts mortality and renal deterioration in patients with chronic kidney disease.
Pharmacy Times interviewed Jun Ling Lu, MD, assistant professor, Department of Medicine, University of Tennessee Health Science Center, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association between long-term aspirin use and the progression of kidney disease.
During the interview, Lu discussed the study findings investigating how the long-term use of aspirin impacts mortality and renal deterioration in patients with chronic kidney disease.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Related Articles
- Effectively Managing Immunizations in the Long-Term Care Setting
September 18th 2025
- Creating a Culture of Quality in Fast-Melt Tablet Development
September 18th 2025